AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Multimodal AI-Guided Recovery Management After Lung Cancer Surgery

RecruitingNAAges 18 Years - 80 YearsAllThe First Affiliated Hospital of Guangzhou Medicaโ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study is a multicenter, prospective, randomized controlled trial designed to evaluate the effectiveness and safety of a multimodal artificial intelligence (AI)-guided postoperative recovery management system in patients after lung cancer surgery. Eligible patients will be enrolled after surgery when their clinical condition is stable and will be randomly assigned to either an AI-guided recovery management group or a usual postoperative care group. Patients in the AI-guided group will receive usual postoperative care plus a multimodal AI-based recovery management system. The system will collect patient-reported symptoms, vital signs, physical activity, respiratory rehabilitation information, recovery-related data, and, when needed, wound or chest-related images or short videos. Based on these data, the system will provide recovery feedback, general nursing advice, respiratory rehabi

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Age 18 years or older. 2. Clinically or pathologically diagnosed with lung cancer. 3. Undergoing lung cancer-related thoracic surgery. 4. Surgical procedures may include video-assisted thoracoscopic surgery, robot-assisted thoracic surgery, or open thoracic surgery. 5. Surgical extent may include wedge resection, segmentectomy, lobectomy, sleeve resection, combined resection, bilobectomy, or pneumonectomy. 6. Clinically stable after surgery and able to participate in symptom assessment and postoperative recovery management. 7. Able to use a smartphone or study device, or has a caregiver who can assist with use. 8. Able to complete patient-reported symptom assessments and postoperative recovery information reporting. 9. Provides written informed consent. Exclusion Criteria: 1. Patients receiving non-surgical treatment only. 2. Patients undergoing bronchoscopy, percutaneous biopsy, or other non-surgical diagnostic or therapeutic procedures only. 3. Clinically unstable after surgery and unable to participate in symptom assessment or recovery management. 4. Requiring prolonged intensive care unit treatment, continuous advanced life support, or continuous intensive medical management. 5. Severe cognitive impairment, psychiatric disorder, language communication disorder, or other conditions that preclude completion of study assessments. 6. Unable to use a smartphone or study device and without a caregiver who can assist with use. 7. Currently participating in another interventional clinical study that may affect the primary outcome of this trial. 8. Any other condition judged by the investigator to make the patient unsuitable for participation in this study.
๐Ÿ’Š

What it tests

  • Conventional Internet-Based Rehabilitation Information
  • Large Language Model-Assisted Rehabilitation Nursing
๐Ÿ“

Where

1 site
the First Affiliated Hospital of Guangzhou Medical University, Guangzhou,Guangdong 510120
Guangzhou, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy